St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Destiny Hinton
Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.
Stories by Destiny Hinton
Blazing a TRAIL in acute myeloid leukemia treatment
See how studies into AML drug reveals new potential target
Bringing science into the clinic with Kelsey Bertrand, MD
Kelsey Bertrand, MD, is building bridges between the lab and the clinic to better treat childhood brain tumors.
St. Jude on Imaging: 5 Discoveries to Explore
Learn about the science of imaging and how different tools and techniques are enabling discovery at St. Jude.
Moving mountains to improve hematological care worldwide
The St. Jude Global Hematology Transversal aims to improve hematological care worldwide.
Shared Resources Spotlight: Experimental Cellular Therapy Laboratory (ECTL)
Experimental Cellular Therapy advances GMP compliant processes for cellular products developed by St. Jude investigators
St. Jude ProteinPaint adopted by the National Cancer Institute for cancer data visualization
Discover why the National Cancer Institute built St. Jude ProteinPaint into their national database.
Seeing is believing: Bringing virtual reality into the clinic
See how St. Jude investigators are using virtual reality in their work.
Study reveals the neurochemical gatekeeper to learning and the key to unlocking it
St. Jude research uncovers neural secrets behind our capacity to learn
Imaging provides a front row seat to metabolic reactions
Learn how MRI is being used for metabolic imaging.
St. Jude takes the lead on prevention and treatment of COVID-19 in vulnerable kids
A St. Jude retrospective study reveals why pediatric cancer treatment should continue during COVID cases.